These IT stocks hit 52-week high despite market turmoil These IT stocks hit 52-week high despite market turmoil Bhagyashree Vivarekar / Friday, September 21, 2018 0 1698 Article rating: 2.5 Despite a huge turmoil in the benchmark indices, majorly led by the NBFCs which also dragged the Nifty IT index 1.4 per cent, the giants TCS and Wipro maintained upsurge and hit record high levels. Read more
Brent oil hovering at the resistance level, looks promising above 80.20 mark Brent oil hovering at the resistance level, looks promising above 80.20 mark Bhagyashree Vivarekar / Friday, September 21, 2018 0 1437 Article rating: 5.0 Brent oil prices witnessed bottom fishing at 70.30 levels in the mid-August 2018 and thereby gave a bounce-back near to its important resistance levels. The prices surged 14 per cent from the said low to a high of 80.13 hit on September 12, 2018. Read more
IPO Analysis : Aavas Financiers IPO Analysis : Aavas Financiers Apurva Joshi / Friday, September 21, 2018 0 8176 Article rating: 4.2 Aavas Financiers plans to raise up to Rs. 1734 cr through offer for sale (OFS) and fresh issue of shares. The OFS includes sale of 1.6 cr shares with face value of Rs 10. The fresh issue will be to raise ~Rs.400 cr by issuing ~48.7 lakh shares. The price band is Rs.818 – Rs.821 per equity share. The offer opens from Sep 25- Sep 28. Read more
SAIL's modernisation and expansion project of Rs 72000 crore near completion SAIL's modernisation and expansion project of Rs 72000 crore near completion Pratik Shastri / Friday, September 21, 2018 0 3120 Article rating: 5.0 Steel Authority of India has announced that it has nearly completed its modernisation and expansion of Rs 72,000 crore. The modernisation and expansion programme was undertaken by the company to increase its capacity to 21 million tonnes per annum (MTPA). Read more
Strides Pharma stock climbs 3.5 per cent on merger of Arrow and Apotex Strides Pharma stock climbs 3.5 per cent on merger of Arrow and Apotex Dnyanada Kulkarni / Friday, September 21, 2018 0 4313 Article rating: 5.0 Strides Pharma’s stock jumped 3.5 per cent during Friday’s opening trade as the decision to merge Arrow and Apotex did not face opposition by the Australian Competition and Consumer Commission (ACCC). Read more